
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. Hypertension
Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1533707
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Left ventricular hypertrophy is often a complication of hypertension and an independent risk factor for cardiovascular events. In Ethiopia, there is a scarcity of data on the prevalence and associated factors of left ventricular hypertrophy among hypertensive adults. The aim of this study was to assess the prevalence and associated factors of left ventricular hypertrophy among adult patients with hypertension attending treatment at two public hospitals in Harar, Eastern Ethiopia from December 20, 2021, to December 20, 2023.Method: A hospital-based cross-sectional study was conducted on 264 hypertensive patients from December 20, 2021, to December 20, 2023. A pretested structured questionnaire and checklist were used to collect data from participants and their clinical records. The data was collected by trained residents, and interns. Data were analyzed using SPSS version 29. Left ventricular mass was measured by transthoracic echocardiography. Associations between categorical variables were assessed using a chi-square test and odds ratio with 95% confidence interval. A logistic regression model was used to identify risk factors of LVH. P values of < 0.05 were considered as statistically significant. Results: The study included 264 adults with hypertension, with a mean age of 58.4 years, and the majority (54.5%) were male. The prevalence of echocardiographically confirmed left ventricular hypertrophy (LVH) was 30.7% (95% CI: 25.1%–36.3%), with mild LVH being the most common type (51%). Significant predictors of LVH included age over 60 years (AOR=5.981, CI=1.832–19.522, P=0.003), khat chewing (AOR=2.676, CI=1.786–9.109, P=0.001), diabetes (AOR=10.430, CI=2.904–37.454, P<0.001), poor medication adherence (AOR=4.132, CI=1.208–14.141, P=0.024), uncontrolled systolic blood pressure (AOR=8.340, CI=2.280–30.512, P=0.001), lack of home blood pressure monitoring (AOR=5.591, CI=1.041–30.012, P=0.045), and longer hypertension duration (AOR=8.766, CI=2.101–36.584, P=0.003). These findings emphasize the need to address modifiable risk factors in managing hypertension to reduce the burden of LVH.Conclusions: The echocardiographic prevalence of LVH was 30.7% in the study population. These results highlight the importance of addressing modifiable risks to reduce LVH burden.Key Words: Hypertension, left ventricular hypertrophy, Echocardiography, Ethiopia
Keywords: Hypertension, left ventricular hypertrophy, Echocardiography, Ethiopia, Eastern Ethiopia
Received: 24 Nov 2024; Accepted: 28 Mar 2025.
Copyright: © 2025 Abebe, Tadesse, Ayele, Mekonnen and Mesfin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Dawit Abebe, School of Nursing and Midwifery, College of Medicine and Health Sciences, Jigjiga University, Jigjiga, Ethiopia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.